ZIVO Bioscience to Present at The Microcap Conference 2025
ZIVO Bioscience (OTCQB: ZIVO), a biotech/agtech R&D company focused on developing therapeutic, medicinal, and nutritional products from proprietary algal cultures, has announced its participation in The Microcap Conference 2025. The event will take place from January 28-30, 2025, in Atlantic City, New Jersey.
The company's management team will deliver a corporate presentation on Thursday, January 30, 2025, at 2:30 PM Eastern Time at Studio 1, Borgata Hotel Casino & Spa. During the conference, management will engage in one-on-one meetings with institutional and individual investors to discuss recent developments, growth strategy, and investment opportunities.
ZIVO Bioscience (OTCQB: ZIVO), una società di ricerca e sviluppo nel campo biotech/agtech focalizzata nello sviluppo di prodotti terapeutici, medicinali e nutrizionali derivati da culture algali proprietarie, ha annunciato la sua partecipazione a The Microcap Conference 2025. L'evento si svolgerà dal 28 al 30 gennaio 2025, ad Atlantic City, New Jersey.
Il team di gestione dell'azienda presenterà una relazione aziendale giovedì 30 gennaio 2025, alle 14:30 ora orientale presso lo Studio 1, Borgata Hotel Casino & Spa. Durante la conferenza, la direzione parteciperà a incontri individuali con investitori istituzionali e privati per discutere dei recenti sviluppi, della strategia di crescita e delle opportunità di investimento.
ZIVO Bioscience (OTCQB: ZIVO), una empresa de I+D en biotech/agtech centrada en el desarrollo de productos terapéuticos, medicinales y nutricionales a partir de cultivos algales propios, ha anunciado su participación en The Microcap Conference 2025. El evento se llevará a cabo del 28 al 30 de enero de 2025, en Atlantic City, Nueva Jersey.
El equipo directivo de la empresa ofrecerá una presentación corporativa el jueves 30 de enero de 2025, a las 2:30 PM hora del Este en Studio 1, Borgata Hotel Casino & Spa. Durante la conferencia, la dirección participará en reuniones uno a uno con inversores institucionales e individuales para discutir los desarrollos recientes, la estrategia de crecimiento y las oportunidades de inversión.
ZIVO Bioscience (OTCQB: ZIVO)는 독점 조류 배양물을 기반으로 치료제, 의약 및 영양 제품을 개발하는 데 초점을 맞춘 생명공학/agtech 연구 개발 회사로 The Microcap Conference 2025에 참여한다고 발표했습니다. 이 행사는 2025년 1월 28일부터 30일까지 뉴저지주 애틀랜틱 시티에서 열립니다.
회사의 경영진은 2025년 1월 30일 목요일, 동부 표준시 오후 2시 30분에 Borgata Hotel Casino & Spa의 Studio 1에서 기업 프레젠테이션을 진행할 예정입니다. 컨퍼런스 동안 경영진은 기관 투자자 및 개인 투자자와 일대일 회의를 통해 최근 개발 현황, 성장 전략 및 투자 기회에 대해 논의할 것입니다.
ZIVO Bioscience (OTCQB: ZIVO), une société de recherche et développement en biotechnologie/agritech spécialisée dans le développement de produits thérapeutiques, médicaux et nutritionnels à partir de cultures algales propriétaires, a annoncé sa participation à The Microcap Conference 2025. L'événement se déroulera du 28 au 30 janvier 2025 à Atlantic City, New Jersey.
L'équipe de direction de l'entreprise fera une présentation d'entreprise jeudi 30 janvier 2025 à 14h30, heure de l'Est au Studio 1, Borgata Hotel Casino & Spa. Au cours de la conférence, la direction participera à des réunions individuelles avec des investisseurs institutionnels et particuliers pour discuter des développements récents, de la stratégie de croissance et des opportunités d'investissement.
ZIVO Bioscience (OTCQB: ZIVO), ein Unternehmen für Forschung und Entwicklung im Bereich Biotechnologie/Agrartechnologie, das sich auf die Entwicklung therapeutischer, medizinischer und ernährungsphysiologischer Produkte aus proprietären Algenkulturen spezialisiert hat, hat seine Teilnahme an The Microcap Conference 2025 angekündigt. Die Veranstaltung findet vom 28. bis 30. Januar 2025 in Atlantic City, New Jersey, statt.
Das Management des Unternehmens wird am Donnerstag, dem 30. Januar 2025, um 14:30 Uhr Eastern Time eine Unternehmenspräsentation im Studio 1 des Borgata Hotel Casino & Spa halten. Während der Konferenz wird das Management Einzelgespräche mit institutionellen und privaten Investoren führen, um über aktuelle Entwicklungen, Wachstumsstrategien und Investitionsmöglichkeiten zu sprechen.
- None.
- None.
Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy, and investment opportunities.
Event: The Microcap Conference 2025
Location: Studio 1, Borgata Hotel Casino & Spa
Date: Thursday January 30, 2025
Time: 2:30 PM Eastern Time
Investors interested in meeting with management can register for the conference here.
About ZIVO Bioscience
Zivo Bioscience, Inc. is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122415215/en/
ZIVO Bioscience
Keith Marchiando, Chief Financial Officer
(248) 452-9866 x130
kmarchiando@zivobioscience.com
Alliance Advisors IR
Tirth T. Patel
(212) 201-6614
tpatel@allianceadvisors.com
Source: Zivo Bioscience, Inc.
FAQ
When and where is ZIVO Bioscience presenting at The Microcap Conference 2025?
What will ZIVO Bioscience discuss at The Microcap Conference 2025?
What is ZIVO Bioscience's main business focus?
How can investors meet with ZIVO management at The Microcap Conference 2025?
